IRIS
Ceribelli, Angela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.357
AS - Asia 1.922
EU - Europa 1.040
AF - Africa 681
SA - Sud America 523
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 7.530
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.294
SG - Singapore 1.160
SC - Seychelles 610
BR - Brasile 462
CN - Cina 457
IT - Italia 239
FI - Finlandia 203
IE - Irlanda 140
DE - Germania 90
GB - Regno Unito 69
FR - Francia 68
IN - India 66
VN - Vietnam 65
NL - Olanda 55
HK - Hong Kong 51
SE - Svezia 30
CA - Canada 28
NG - Nigeria 28
RU - Federazione Russa 24
AR - Argentina 22
MX - Messico 21
MK - Macedonia 20
JP - Giappone 16
ZA - Sudafrica 16
TR - Turchia 15
BD - Bangladesh 14
CZ - Repubblica Ceca 14
IQ - Iraq 14
PL - Polonia 14
ES - Italia 13
EC - Ecuador 12
BE - Belgio 10
MA - Marocco 9
PK - Pakistan 9
CH - Svizzera 8
PH - Filippine 8
AE - Emirati Arabi Uniti 6
CO - Colombia 6
IL - Israele 6
PE - Perù 6
TN - Tunisia 6
UA - Ucraina 6
UZ - Uzbekistan 6
VE - Venezuela 6
AT - Austria 5
CL - Cile 5
ID - Indonesia 5
JO - Giordania 5
KR - Corea 5
DK - Danimarca 4
JM - Giamaica 4
NO - Norvegia 4
AL - Albania 3
AU - Australia 3
BG - Bulgaria 3
KE - Kenya 3
LB - Libano 3
PT - Portogallo 3
RO - Romania 3
TT - Trinidad e Tobago 3
DZ - Algeria 2
EE - Estonia 2
EG - Egitto 2
HN - Honduras 2
HU - Ungheria 2
LT - Lituania 2
PA - Panama 2
PY - Paraguay 2
SA - Arabia Saudita 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
BS - Bahamas 1
BW - Botswana 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EU - Europa 1
GY - Guiana 1
HR - Croazia 1
IS - Islanda 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LV - Lettonia 1
ML - Mali 1
MM - Myanmar 1
MY - Malesia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
UG - Uganda 1
UY - Uruguay 1
Totale 7.530
Salva come PNG Salva come JPEG
Città #
Chandler 606
Singapore 447
Dallas 354
The Dalles 285
Ashburn 268
Shanghai 227
Helsinki 203
Boardman 168
New York 146
Beijing 141
Dublin 140
Wilmington 133
Los Angeles 68
Milan 57
Paris 57
San Mateo 54
Hong Kong 51
Amsterdam 40
São Paulo 36
Ann Arbor 34
London 31
Benin City 27
Council Bluffs 27
Pune 27
Ho Chi Minh City 26
Lawrence 26
Princeton 26
Leawood 23
Santa Clara 23
Naples 21
Phoenix 21
Belo Horizonte 20
Columbus 20
Brooklyn 17
Chennai 16
Stockholm 16
Woodbridge 16
Seattle 15
Fairfield 13
Hanoi 13
Rio de Janeiro 13
Rome 12
Brno 11
Montreal 11
San Francisco 11
Tokyo 11
Warsaw 11
Boston 10
Brasília 10
Brussels 10
Falkenstein 9
Johannesburg 9
Mexico City 9
Munich 9
Skopje 9
Chicago 8
Sassari 8
Frankfurt am Main 7
Hyderabad 7
Assago 6
Aurora 6
Baghdad 6
Curitiba 6
Lima 6
Orem 6
San Diego 6
Trieste 6
Amman 5
Bitola 5
Caxias do Sul 5
Dhaka 5
Fortaleza 5
Houston 5
Jundiaí 5
Kocaeli 5
Osasco 5
Poplar 5
Porto Alegre 5
Praia Grande 5
San Jose 5
Tashkent 5
Toronto 5
Abbiategrasso 4
Americana 4
Betim 4
Buenos Aires 4
Buffalo 4
Da Nang 4
Denver 4
Guarulhos 4
Guayaquil 4
Kingston 4
Moscow 4
Oslo 4
Redwood City 4
Salvador 4
Seoul 4
Tel Aviv 4
Turin 4
Usmate Velate 4
Totale 4.319
Salva come PNG Salva come JPEG
Nome #
Serum anti-phospholipid antibody prevalence and cardiovascular significance in the general population of the camelia study 674
Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study 184
UTILIZZO DELLA MEPACRINA COME TERAPIA DELLE MANIFESTAZIONI CUTANEE NELLE CONNETTIVITI 123
Acute phase reactions after zoledronic acid infusion: protective role of 25-OH vitamin D and previous oral bisphosphonate therapy 116
Personalized medicine in rheumatology : the paradigm of serum autoantibodies 109
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 104
Anti-phospholipid antibody prevalence and association with subclinical atherosclerosis and atherothrombosis in the general population 103
Safety issues and concerns of new immunomodulators in rheumatology 94
A case of psoriatic arthritis triggered by SARS-CoV-2 infection 93
Additional organs involved in antiphospholipid syndrome : eye, ear-nose-throat, lung, gastroenteric system, endocrine glands 89
Serum antinuclear and extractable nuclear antigen antibody prevalence and associated morbidity and mortality in the general population over 15 years 89
Autoantibodies as biomarkers for interstitial lung disease in idiopathic inflammatory myositis and systemic sclerosis: The case of anti-eIF2B antibodies 86
Gamma-delta T lymphocytes and 25-hydroxy vitamin D levels as key factors in autoimmunity and inflammation : the case of zoledronic acid-induced acute phase reaction 86
Anti-MDA5 Antibody Linking COVID-19, Type I Interferon, and Autoimmunity: A Case Report and Systematic Literature Review 83
A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy 82
Anti-RNA polymerase III antibodies: a marker of systemic sclerosis with rapid onset and skin thickening progression 78
Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis 77
Antigen Reactivity and Clinical Significance of Autoantibodies Directed Against the Pyruvate Dehydrogenase Antigen Complex in Patients With Connective Tissue Disease 76
Lessons learned from twins in autoimmune and chronic inflammatory diseases 73
Anti-TNF-alpha treatment in rheumatoid arthritis with anti-Ro/SSA antibodies. Analysis of 17 cases among a cohort of 322 treated patients 73
Effects of type II collagen epitope carbamylation and citrullination in HLA-DR4+ monozygotic twins discordant for rheumatoid arthritis 71
DNA Methylation Signature in Monozygotic Twins Discordant for Psoriatic Disease 69
Suspected and unsuspected factors in the multifaceted immunopathology of viral hepatitis 69
Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis/dermatomyositis 69
Anti-RNA polymerase III antibodies as a risk marker for early gastric antral vascular ectasia (GAVE) in systemic sclerosis 68
Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease? 68
Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma 68
The Immune Response and the Pathogenesis of Idiopathic Inflammatory Myositis : a Critical Review 67
PFAPA syndrome and Behçet’s disease : a comparison of two medical entities based on the clinical interviews performed by three different specialists 67
Anti-argonaute2 (Ago2/Su) and -Ro antibodies identified by immunoprecipitation in primary anti-phospholipid syndrome (PAPS) 65
Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis 65
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases 63
[TNF-alpha inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunologic effects] 62
Disease knowledge index and perspectives on reproductive issues: A nationwide study on 398 women with autoimmune rheumatic diseases 62
AUTOANTIBODY TO RNA-PROTEIN COMPLEX DETECTED BY QUANTITATIVE PCR 61
Nailfold videocapillaroscopy and serum VEGF levels in scleroderma are associated with internal organ involvement 61
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course. 60
Detection of anti-mitochondrial antibodies by immunoprecipitation in patients with systemic sclerosis 59
ANTI-RNA POLYMERASE III ANTIBODIES AS A RISK MARKER FOR EARLY DEVELOPMENT OF GASTRIC ANTRAL VASCULAR ECTASIA IN SYSTEMIC SCLEROSIS 58
MicroRNAs in rheumatoid arthritis 57
Short-Term Adverse Events and Antibody Response to the BNT162b2 SARS-CoV-2 Vaccine in 4156 Health Care Professionals 56
Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers 56
Impact of chronic exposure to 5-alpha reductase inhibitors on the risk of hospitalization for COVID-19: a case-control study in male population from two COVID-19 regional centers of Lombardy, Italy 56
Humoral Response Against LL-37 in Psoriatic Disease: Comment on the Article by Yuan et al 55
Comment on: Inflammatory myopathy associated with anti-mitochondrial antibodies: A distinct phenotype with cardiac involvement 55
A new immunoprecipitation-real time quantitative PCR assay for anti-Th/To and anti-U3RNP antibody detection in systemic sclerosis 53
Reference standards for the detection of anti-mitochondrial and anti-rods/rings autoantibodies 53
An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations 52
Elastic properties of the ascending aorta in patients with rheumatoid arthritis 52
Seronegative reactive spondyloarthritis and the skin 52
The Th17 axis in psoriatic disease : pathogenetic and therapeutic implications 50
Environmental triggers for connective tissue disease: the case of COVID-19 associated with dermatomyositis-specific autoantibodies 50
Long-term Outcome of Children Born to Women with Autoimmune Rheumatic Diseases: A Multicentre, Nationwide Study on 299 Randomly Selected Individuals 49
Complement cascade in systemic lupus erythematosus: analyses of the three activation pathways 49
Clinical Significance of Antinucleolar Antibodies: Biomarkers for Autoimmune Diseases, Malignancies, and others 49
MicroRNAs and autoimmunity 48
Clinical Trials Supporting the Role of the IL-17/IL-23 Axis in Axial Spondyloarthritis 48
Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies 47
The geoepidemiology of autoimmune liver disease 46
Isotype switching and titer variation of anti-Ro/SSA antibodies over time in 100 patients with undifferentiated connective tissue disease (UCTD) 46
Autoantibodies to survival of motor neuron complex in patients with polymyositis: immunoprecipitation of D, E, F, and G proteins without other components of small nuclear ribonucleoproteins 45
MicroRNA-146a in autoimmunity and innate immune responses 45
Evaluation of a novel particle-based assay for detection of autoantibodies in idiopathic inflammatory myopathies 44
Calcinosis in poly-dermatomyositis: clinical and laboratory predictors and treatment options 43
The interplay of epigenetics and epidemiology in autoimmune diseases: time for geoepigenetics 43
Lymphocyte modulation by tofacitinib in patients with rheumatoid arthritis 43
Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank 43
Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy 43
Neuropsychiatric aid in children born to patients with rheumatic diseases 43
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting 42
Anti-cardiolipin and anti-beta2-glycoprotein I antibodies: performance of new commercial ELISA kits 42
Psoriatic arthritis induced by anti-PD1 and treated with apremilast: a case report and review of the literature 42
Atypical clinical presentation of a subset of patients with anti-RNA polymerase III--non-scleroderma cases associated with dominant RNA polymerase I reactivity and nucleolar staining 42
ANTICORPI ANTI-CCP: LIMITI E SVANTAGGI 42
Lupus T cells switched on by DNA hypomethylation via microRNA? 41
Autoantibodies to transcription intermediary factor TIF1β associated with dermatomyositis 41
Unusual association between pure red cell aplasia and primary Sjögren's syndrome: a case report 41
Aortic stiffness and left ventricular hypertrophy in rheumatoid arthritis: comment on the article by Rudominer et al 41
Gender and ethnicity differences in the prevalence of scleroderma-related autoantibodies 40
Differential reactivity to IMPDH2 by anti-rods/rings autoantibodies and unresponsiveness to pegylated interferon-alpha/ribavirin therapy in US and Italian HCV patients 40
Cancer in connective tissue disease 39
Treatment with etanercept in six patients with chronic hepatitis C infection and systemic autoimmune diseases 39
Treatment of lupus skin involvement with quinacrine and hydroxychloroquine 39
Frequent coexistence of anti-topoisomerase I and anti-U1RNP autoantibodies in African American patients associated with mild skin involvement: a retrospective clinical study 38
Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera 37
Evaluation of mortality, disease activity, treatment, clinical and immunological features of adult and late onset systemic Lupus erythematosus 37
Rpp25 is a major target of autoantibodies to the Th/To complex as measured by a novel chemiluminescent assay 37
Cardiological features in idiopathic inflammatory myopathies 37
International cohort study of 73 anti-Ku-positive patients: association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis 37
LUPUS ERITEMATOSO SISTEMICO AD ESORDIO TARDIVO: CARATTERISTICHE CLINICHE ED IMMUNOLOGICHE 37
Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study 37
mRNA COVID-19 vaccine booster fosters B- and T-cell responses in immunocompromised patients 37
The evolving scenario of HCV-related mixed cryoglobulinemia and B-cell lymphoma in the era of direct-acting antivirals 37
Medical cannabis and cannabinoids in rheumatology: where are we now? 36
MicroRNAs in Axial Spondylarthritis: an Overview of the Recent Progresses in the Field with a Focus on Ankylosing Spondylitis and Psoriatic Arthritis 36
Primary biliary cirrhosis-related autoantibodies in a large cohort of italian patients with systemic sclerosis 36
ANTICORPI ANTI-SU NELLA SINDROME DA ANTICORPI ANTI-FOSFOLIPIDI PRIMARIA (PAPS) 35
Coexistence of anti-RNA polymerase III and anti-U1RNP antibodies in patients with systemic lupus erythematosus: two cases without features of scleroderma 35
Elevated signal transducers and activators of transcription 1 correlates with increased C-C motif chemokine ligand 2 and C-X-C motif chemokine 10 levels in peripheral blood of patients with systemic lupus erythematosus 35
ANTICORPI ANTI-TH/TO NELLA SCLEROSI SISTEMICA (SSC): CORRELAZIONI CLINICHE E IMMUNOLOGICHE 34
Totale 6.384
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.479
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.479
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021249 0 0 0 0 0 71 32 16 61 26 2 41
2021/2022147 8 2 2 33 2 1 4 18 12 16 29 20
2022/20231.483 77 103 122 191 129 142 5 180 254 132 128 20
2023/20241.167 127 77 257 92 48 181 77 32 20 60 64 132
2024/20252.428 38 37 636 57 83 227 144 131 293 400 207 175
2025/20262.113 792 265 412 341 191 112 0 0 0 0 0 0
Totale 7.610